Pacific Biosciences of California Inc (PACB.OQ)
PACB.OQ on NASDAQ Stock Exchange Global Select Market
2.54USD
1 Aug 2013
2.54USD
1 Aug 2013
Price Change (% chg)
$-0.05 (-1.93%)
$-0.05 (-1.93%)
Prev Close
$2.59
$2.59
Open
$2.64
$2.64
Day's High
$2.64
$2.64
Day's Low
$2.54
$2.54
Volume
2,070
2,070
Avg. Vol
--
--
52-wk High
--
--
52-wk Low
--
--
About
Pacific Biosciences, Inc. develops Deoxyribonucleic Acid (DNA) sequencing platform. The Company designs and develops a method for single-molecule DNA sequencing that was developed through collaboration between the research groups of Harold Craighead and Watt Webb at Cornell University, United States. The Company's single... (more)
Overall
| Beta: | -- |
| Market Cap (Mil.): | $171.78 |
| Shares Outstanding (Mil.): | 66.32 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| PACB.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 66.39 | 37.76 |
| EPS (TTM): | -1.56 | -- | -- |
| ROI: | -58.44 | 4.99 | 18.76 |
| ROE: | -63.99 | 9.80 | 19.59 |
Competitors
| Price | Change | |
|---|---|---|
| Illumina, Inc. (ILMN.OQ) | $81.15 | +1.33 |
| Life Technologies Corp. (LIFE.OQ) | $74.69 | +0.09 |
| Roche Holding Ltd. (ROG.VX) | CHF228.00 | -3.50 |
| Complete Genomics, Inc. (GNOM.OQ) | -- | -- |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: S&P Capital IQ Quantitative Report
|
$69.00
|
|
Provider: Wright Reports
|
$460.00
|
|
Provider: Pechala's Reports
|
$15.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

